Bangalee A, Hanley S, Bangalee V. MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach. S Afr Med J [Internet]. 2022 Oct. 5 [cited 2026 Apr. 18];112(10):787-90. Available from: https://samajournals.co.za/index.php/samj/article/view/256